61597-55-5

Usage

Uses

Used in Pharmaceutical Industry:
15,16-Epoxy-12R-hydroxylabda-8(17),13(16),14-triene is used as a potential therapeutic agent for its anti-inflammatory properties, which can help in managing inflammation-related conditions.
Used in Oncology Research:
In the field of oncology, 15,16-Epoxy-12R-hydroxylabda-8(17),13(16),14-triene is used as a compound with anti-tumor activity, indicating its potential in developing treatments for various types of cancer.
Used in Microbiology:
15,16-Epoxy-12R-hydroxylabda-8(17),13(16),14-triene is utilized as an anti-microbial agent, suggesting its possible application in combating microbial infections and contributing to the development of new antibiotics.
Used in Natural Product Chemistry:
Due to its complex structure and potential biological activities, 15,16-Epoxy-12R-hydroxylabda-8(17),13(16),14-triene is used as a subject of research in natural product chemistry, with the aim of understanding its properties and exploring its potential applications in drug discovery.

Upstream product

• 383159-58-8 1-(3-furyl)-2-[(1S,4aS,8aS)-1,2,3,4,4a,5,6,7,8,8a-decahydro-5,5,8a-trimethyl-2-methylene-1-trans-naphthyl]methylketone 
• 434284-14-7 N-methoxy-N-methyl-2-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)acetamide 
• 190264-38-1 2-((1R,2R,4aS,8aS)-2-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)-N-methoxy-N-methylacetamide 
• 3243-36-5 (1S,4aS,8aS)-1,2,3,4,4a,5,6,7,8,8a-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthaleneacetaldehyde 
• 909794-72-5 (R)-1-(2-(triisopropylsilyloxy)furan-3-yl)-2-((1S,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)ethanol 
• 564-20-5 (3aR)-(+)-sclareolide 
• 66890-69-5 8α-hydroxy-15,16-epoxy-labda-13(16),14-dien-12-one 
• 958885-86-4 3-[(1R)-2-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylidene-decahydronaphthalen-1-yl]-1-hydroxyethyl]-2,5-dihydrofuran-2-one 
• 22037-28-1 3-bromofurane 

Downstream Products

• 1011287-51-6 (1-(furan-3-yl)-2-((1S,8aS)-5,5,8a-trimethyl-2-methylidenedecahydronaphthalen-1-yl)ethoxy)triisopropylsilane 

Relevant academic research and scientific papers

Synthesis of (+)-zerumin B using a regioselective singlet oxygen furan oxidation

(Chemical Equation Presented) A short and efficient synthesis of the antitumor diterpenoid (+)-zerumin B has been accomplished starting from (+)-sclareolide. At the heart of the synthetic strategy lies the regioselective formation of the α-substituted γ-hydroxybutenolide moiety of zerumin B. This was achieved by means of a [1,4] O→C triisopropylsilyl migration followed by singlet oxygen (1O2) oxidation of the resulting 2-triisopropylsilyl-3-(α-hydroxy)alkylfuran.

Trypanocidal labdane diterpenoids from the seeds of Aframomum aulacocarpos (Zingiberaceae)

Two novel labdane type diterpenoids, 8β(17)-epoxy-14,15,16-trihydroxylabd-12(E)-ene (aulacocarpin C) and 15,16-epoxy-14ξ,16ξ-dimethoxylabda-8(17),12-(E)-diene (aulacocarpin D) together with the known aulacocarpin A and B; 14,15-epoxy-8(17),12(E)-labdadien-16-al, coronarin E, and 15,16-epoxy-12β-hydroxy-labda-8(17)-13(16),14-triene were isolated from the seeds of Aframomum aulacocarpos. To the best of our knowledge, the last compound was isolated from a natural source for the first time. Acid hydrolysis of aulacocarpin D led to another new labdane type diterpenoid, 15,16-epoxy-12β-methoxylabda-8(17)-13(16),14-triene. The structures of all compounds were established on the basis of their spectroscopic data. These new compounds exhibit moderate trypanocidal activity.

Synthesis of chinensines A-E

(Chemical Equation Presented) Short and efficient syntheses of coronarin E (4) and chinensines A-E (5-9) have been accomplished. The use of two different types of reaction of singlet oxygen (1O2) lies at the heart of the synthetic st

Facile access to labdane-type diterpenes: Synthesis of coronarin C, zerumin B, labda-8(17), 13(14)-dien-15,16-olide and derivatives from (+)-manool

A practical method for the synthesis of optically active labdane-type diterpenes from (+)-manool 8, is described. We prepared the natural labdane-type diterpene 5 via key intermediate peroxide 9 and coronarin C 1, compound 8 and zerumin B 6 via a furan photosensitised oxygenation reactions.

Synthesis and stereochemistry of the antitumor diterpenoid (+)-zerumin B

Starting from commercially available (+)-sclareolide, the first synthesis of zerumin B was achieved by a concise, highly efficient pathway featuring stereoselective addition of a new silyloxyfuryltitanium reagent to an aldehyde intermediate and silyloxyfuran oxyfunctionalization as key steps. The synthesis established the relative and absolute configuration of zerumin B along with its identity with a purportedly new diterpenoid isolated from the plant Renealmia alpinia.

Synthesis of the marine furanoditerpene (-)-marginatone

A synthesis of the marine labdane furanoditerpene (-)-marginatone 1 has been accomplished by a short sequence of reactions starting from (+)-coronarin E 5. The key step is the stereocontrolled-intramolecular electrophilic cyclisation of the (+)-dihydrocoronarin E 6, to the tetracyclic marginatane skeleton 7, which is subsequently functionalized by allylic oxidation to give 1. As (+)-coronarin E 5 was previously synthesized from (-)-sclareol 10, the herein reported preparation constitutes the first formal total synthesis of (-)-marginatone 1, by which its absolute configuration has been confirmed.